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Abstract To investigate the intervention therapy effect
on the growth of malignant melanoma, we have made an
observation of expression levels of Ang2 in malignant
melanoma cells, which was transduced by small interfering
RNA (Ang2-siRNA) of Ang2 in vitro and in vivo. We
successfully constructed Ang2-siRNA lent virus, and con-
structed nude mice model by transplanting malignant
melanoma. Ang2-siRNA lent virus inhibited Ang2 mRNA
of malignant melanoma in vitro and in vivo, and inhibited
malignant melanoma tumor growth at the same time.
Ang2-siRNA lent virus can interfere expression levels of
Ang2 in malignant melanoma cells, inhibit tumor growth,
and silent Ang2 gene expression, which may pave a new
way for clinical gene therapy of malignant melanoma.
Keywords Ang2  Lent virus  RNAi  Malignant
melanoma
Introduction
Angiogenesis is extremely important in multiply physio-
logical and pathological processes [1]. When there are a
large number of angiogenic cytokines, neovascular for-
mation will be activated in vivo, which may cause
tumorogenesis. The angiopoietin (Ang) family is a newly
discovered group of cytokines with specific roles in regu-
lation of vascular endothelial. Ang2 is a member of the
family [2], which is one of the important initial factors in
tumor angiogenesis and proliferation of endothelium [3],
related with the density of tumor blood vessels, tumor
stage and prognosis of survival closely [4]. Ang2 widely
expresses in vascular system of human tumors, but very
limitedly in normal tissues. Our previous experiments have
been confirmed to inhibit the expression of Ang2 gene can
suppress angiogenesis [5], making it become an attractive
candidate target in anti-angiogenesis in cancer therapy [6].
Malignant melanoma is a type of human tumor, formed
from transformation of malignant melanocytes, with the
characteristics of strong invasion and metastasis abilities,
as well as poor prognosis. Its prognosis is particularly
affected by low sensitivity of conventional treatments such
as chemotherapy, radiotherapy and immunotherapy, mainly
in immune and gene therapy in developed countries,
besides invasion and metastasis abilities [7]. RNA inter-
ference (RNAi) is a gene silencing process mediated by
small interfering RNA (siRNA) which is transferred from
double-stranded RNA (dsRNA) [8]. siRNA guides RISC to
specifically degradate the homologous mRNA through
pairing the specific homologous fragment, leading to the
inhibition of gene expression. Therefore, a small fragment
of siRNA can induce efficient gene silencing [9], and thus
it can make use of RNAi to block the target gene expres-
sion to achieve the purpose of diseases therapy.
Lentiviral vectors can infect non-dividing cells. The
target gene can be integrated into the genome of infected
cells, maintain long-term expression and cause limited
immune response, therefore it has become an ideal gene
transfer vector with widespread concentration because of
its advantage. Lentiviral vector and can express stable
siRNA against Ang2 long-term in tissues, whose gene
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shows high expression in malignant melanoma [10], so we
can build of Ang2-siRNA lentivirus, and make use of its
interference with the Ang2 gene expression to inhibit tumor
angiogenesis, vessel growth, and tumor proliferation, in
order to provide a theoretical basis for clinical treatment of
malignant melanoma.
Methods
Restriction sites of the plasmid
In order to determine XbaI restriction enzyme sites are
located at pre-constructed plasmid vector, plasmid pSi-
lencer 1.0-U6-Ang2-siRNA and plasmid pNL-EGFP, we
used plasmid map analysis by Gene Tool software.
Lent viral production and transduction
We recovered and purified the Ang2-siRNA fragments and
pNL-EGFP fragments, which contained the U6 promoter,
through being digested by XbaI, with electrophoresis, and
the gel extraction kit, and dephosphorylated the recycling
pNL-EGFP terminal at the same time. PNL-EGFP frag-
ments and ang2-siRNA fragments were connected at a
condition, of which molar concentration ratio is 10:1,
products were transduced into DH5a cells, cultured at
Amp ? LB plates. Screening positive colonies to extract
the recombinant plasmid, the extracted recombinant plas-
mid were digested by XbaI restriction enzyme, and identi-
fied by electrophoresis. After restriction enzyme digestion,
and electrophoresis identification of the recombinant plas-
mids, correct recombinant plasmids were sequenced.
293T cells were trans infected using the CaPO4 method,
producing EGFP viral 293T
We take 10 plates of 10 cm of 70 % cell abundance 293T
cells, adding 10 ll chloroquine of 25 mM in each plate,
mixed gently, put back into the incubator for 1 h, and then
changed the cultural media. We took X ll (100 lg) pNL-
EGFP Y ll (70 lg) pHelper, Z ll (60 lg) pVSVG, and
added into the 50 ml centrifuge tube and gently mixed,
then added 450 ll 2.5 mol/l CaCl2, and TE supplement
added to 6,250 ll, gently blowing mixed. 6,250 ll HEPES
was added in drop wise, rapid mixing, put aside for 25 min.
10 plates of 293T cells was added with chloroquine, were
replaced with new serum-free DMEM, adding 1,250 ll of
the above mixture per plate, gently shaking, placed at the
incubator for 10–12 h. We observed the expression levels
of the reporter gene EGFP under an inverted fluorescence
microscope, and then discarded the old medium, adding
new serum-containing DMEM to terminate trans infection.
After terminating trans infection at 12, 24, 48 h, it was
observed by fluorescence microscopy, photographed, and
saved, and then collected viral supernatant, it was then
stored for further experiments.
Cells were plated at a density of 2 9 105–4 9 105 293T
cells per well in 6-well plates. When the cell abundance
about 75 %, added the same amount of virus stock solution
according to the gradient, respectively, diluted 105 virus
solution. After incubated at 37 C for 24 h, replaced
DMEM medium and continued to foster. 24–48 h later,
inverted fluorescence microscope was used to detect GFP
expression levels to calculate the virus titer.
Infection of A375 cells by lent virus in vitro,
and the detection of Ang2 mRNA level
Select multiplicity of infection (MOI) for 10,20,40,80 to infect
A375 cells, blood cell counting plate to calculate the effi-
ciency of infection, choose the appropriate multiplicity of
infection. A375 cells in the logarithmic growth phase
Fig. 1 a Plasmid map of pNL-
EGFP and pSilencer1.0-U6-
Ang2. b Electrophoresis of
plasmid digested by XbaI
Fig. 2 a Plasmid map of pNL-EGFP-U6-Ang2. b Plasmid pNL-
EGFP-U6-Ang screened by XbaI
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Digested by trypsin, and 2 9 104/mL single cell suspension
was made, cultured in 6 well culture plate. The experiment
was divided into four groups: group A virus-infected cells,
negative control group; group B was added the culture med-
ium, blank control group; C and D adding different RNAi
target virus-infected cell. According the MOI, adding the
appropriate amount the virus for infection, after 2–3 days,
inverted fluorescence microscope was used for observation,
taking pictures, and was saved. Total cellular RNA were
extracted from the A, B, C, and D group, trans scripted into
cDNA reversely, Ang2 (183 bp) was amplified specifically,
Ang2 forward (50-GGGCATAATTGTGCTTGACTGG-30),
and reverse (50-ATGGTCTTTAGAATTGG GTCACTGG-
30) primers, GADPH forward 5-GCACCGTCAAGGCTGA-
GAAC-30), and reverse (50-TGGTGAAGACGCCAGTGGA-
30) primers. GADPH was as an endogenous control for the
implementation of the fluorescent quantitative RT-PCR to
detect Ang2 mRNA expression. (7500 Real Time PCR Sys-
tem, Reps: 45–95 C 5 s, 60 C 34 s, 95 C 15 s). Calculated
RNAi inhibition of Ang2 expression efficiency (DDCt =
DCt1 - DCt2) by the formula N1/N2 = 2 - DDCt.
Xenografts in nude mice model
Collection of A375 cells in logarithmic growth phase, cells
was digested by 0.25 % trypsin, and made into single cell
suspension, adjust the cell density to approximately
5 9 107/ml inoculated he 100 ll above A375 single cell
suspension in nude mice right armpit subcutaneously. Nude
living conditions and tumor formation were observed daily
for the establishment of a nude mouse model.
Lent virus infection of A375 cells in vivo, and observation
of tumor growth, Ang2 mRNA level detected
Measuring tumor length (L) and width (W) diameter every
five days. By improving method to calculate the tumor vol-
ume of Tang et al. [12], Smoller et al. [13], according to the
formula V = (L 9 W2) 9 3.14/6 to calculate tumor volume.
When the tumor grew to about 6 9 6 mm (22 days), nude
mice were divided into blank control group, no-load group,
experimental group, (n = 5). Nude mice of each group were
treated with a multi-point injection of the tumor pNL-EGFP-
of Ang2-siRNA lent virus solution (experimental group),
pNL-EGFP lent virus solution (no-load group), PBS (blank
group) 200 ll every other day, and intra-abdominal injection
of 500 ll to for strengthening. Measuring and calculation of
tumor volume, made tumor growth curve.
After 42 days of A375 cells inoculated, 4 % chloral hydrate
intra peritoneal injection of nude mice for anesthesia, we then
made incision of the tumor surface, and complete stripping of
tumor. Total RNA from tumor tissue were extracted, and
reversely transcribed into cDNA, was amplified by PCR
instrument, amplification products were used for agarose gel
electrophoresis image analysis; and the implementation of the
efficiency of fluorescent quantitative RT-PCR to determine
RNAi inhibition of Ang2 expression (7300 Real Time PCR
System Reps: 40, 95 C 5 s, 57.5 C 1 min, 95 C 30 s).
Statistical analyses
SPSS11.5 was used for statistical analysis, independent sam-
ples t test, P \ 0.05 was considered statistically significant.
Results
Identification of the vector
Plasmid pNL-EGFP and pSilencer1.0-U6-Ang2-siRNA
digested by XbaI restriction enzyme
From the plasmid map of PNL-EGFP and pSilencer1.0-U6-
Ang2-siRNA (Fig. 1a), there are XbaI restriction sites at
both of the plasmid. There was only one XbaI restriction
sites of pNL-EGFP, digested by XbaI to be a line
Fig. 3 Identification
sequencing of positive clones.
a Identification sequencing of
pNL-EGFP-U[-Ang2-I.
b Identification sequencing of
pNL-EGFP-U[-Ang2-II
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molecular, showing a ladder by Electrophoresis (Fig. 2b,
lane 3). There were 3 ladders if is not digested by electro-
phoresis. That is: super coiled circular plasmid, open-loop
plasmid, open-loop with a gap in the plasmid (Fig. 2b, lane
2). There were two XbaI restriction sites at plasmid pSi-
lencer1.0-U6-Ang2-siRNA. Plasmid pSilencer1.0-U6-
Ang2-siRNA could be digested into fragments of a 3 and
400 bp. There were two ladders by electrophoresis (Fig. 2b,
lanes 5, 7). If they were not been digested, which is a ring
form, three ladders could be seen when electrophoresis
(Fig. 2b, lanes 4, 6).
Identification of plasmid pNL-EGFP-U6-Ang2
Mixed the U6-Ang2 fragments from pSilencer1.0-U6-of
Ang2-of siRNA plasmids with pNL-EGFP vectors
(Fig. 1a) digested by the XbaI enzyme (Fig. 1a). Legating
reaction of U6-Ang2 fragments and pNL-EGFP vectors at
the molar ratio of 10:1, and screened positive clones were
digested by XbaI, and identified by electrophoresis, if the
connection was successful, U6-of Ang2 fragment would be
cut (Fig. 2a).
Screened results: lane 1,2,3,4,6,7,8 may be the pNL-EGFP-
U6-Ang2 (Fig. 2b). Positive clones were screened by restric-
tion enzyme, electrophoresis, which was sequenced, the
sequencing results showed that the connection was successful
pNL-EGFP-U6-Ang2 plasmid strains were obtained (Fig. 3).
Lent virus production
Co-trans infected 293T cells by plasmids pNL-EGFP,
pVSVG and pHelper, obtained EGFP virus
293T cells were derived from human renal epithelial cell
line 293 cells, which are triploid of human cell. Plasmid
containing the replication origin sites and the promoter
region of SV40 can be replicated in cells. When 293T cells
were in the logarithmic growth phase, the pNL-EGFP,
pVSVG, pHelper plasmids trans-ducted into the cells at the
same time. If the green fluorescence observed under a
fluorescence microscope after 12 h, it was indicated that
transinfection was successful, and the media was changed
immediately to terminate the process of transinfection
reaction.
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After the first 12 h of termination of the trans infection
reaction, we observed bits and pieces of green fluorescence
(Fig. 4a); barely into a piece of bright green fluorescence in
the first 24 h (Fig. 4b); dazzling green fluorescence still
being visible in the first 48 h, while some cells detached
from the wall floating in the culture media (Fig. 4c);
honeycomb-like fluorescence appeared after 60 h, the cell
sheet was scattered in the culture media (Fig. 4d). That
meant a large number of cellular lysates, which resulting in
many EGFP virus.
Lent virus primary liquid titer
When 293T cells were in the logarithmic growth phase, the
lent virus infected 293T cells with different concentrations
and observed under fluorescence microscope. Infected cells
with visible fluorescence could be seen in 5 pates infected
cells, but the intensity of fluorescence was different: with
the reduction of virus concentration, the brightness of the
green fluorescence decreasing (Fig. 5). The titer value of
lent virus primary solution = (42 9 104 9 10)/500 ll =
8.4 9 103/ll.
Lent virus infection of A375 cells in vitro,
and the detection of Ang2 mRNA level
Lent virus infection of A375 cells to determine
the appropriate multiplicity of infection
When A375 cell growth state meet the requirements, we
selected infected A375 cells, the multiplicity of infection of
which was 10, 20, 40, 80, and observed under fluorescence
microscope camera (Fig. 6), the higher of the multiplicity of
infection, the brighter of the green fluorescence. The cells
were digested into single cell suspension, counting with
blood cell count plate (Table 1), the appropriate multiplicity
of infection of 80 was used in the subsequent experiments.
Ang2 mRNA level by real-time fluorescence quantitative
RT-PCR
Total RNA of A375 cells were extracted from group A, B,
C, D, and then reversely trans-scripted into cDNA,
respectively. Drawing the same amount of cDNA template,
real-time fluorescence quantitative RT-PCR was performed
Fig. 5 Lent virus infection at different concentrations in 293T cells (910)
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for Ang2 to obtain RNAi inhibition of Ang2 gene expres-
sion efficiency (Table 2, DCt = Ang2 Ct—GADPH Ct;
mean DDCt = mean DCt1-mean DCt2). This meant that
EGFP-Ang2-I lentivirus suppressed the Ang2 gene
expression by 68.31 % (Fig. 7), and the difference was
statistically significant (P \ 0.05); EGFP-Ang2-II lent
virus suppression efficiency is low, the difference was not
statistically significance (P [ 0.05), also groups A and B
inhibition efficiency was not statistically significant
(P [ 0.05). So Ang2-EGFP lent virus was used in the
Subsequent animal experiments.
Lent virus interfere with the growth of transplanted
tumors in nude mice in vivo
We inoculated A375 cells subcutaneously in the right
armpit to establish xenografts in nude mice. After an
incubation period of 5–7 days, tumor could be visible at the
inoculated parts of nude mice. After 22 days of inoculation
of the A375 cells, nude mice tumors could grow to a size of
approximately 6 9 6 mm. Intervention experiment was
carried on, and then observation, measurement of subcu-
taneous tumor size of the blank group, the no-load group,
Fig. 6 The situation of malignant melanoma cells in different multiplicity of infection conditions infection (940)
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and the experimental group (Fig. 8a–e). After inoculation
of nude mice, measured and calculated of tumor volume at
5, 10, 15, 20, 25, 30, 35, and 40 days, and then drawn
tumor growth curve (Fig. 8f).
There was no significant statistical difference between
the blank group and no-load group (P[0.05). There was
significant statistical difference between the experimental
group and the blank group or no-load group (P\0.01).
Ang2 mRNA levels of transplanted tumor in nude mice
by implementation of fluorescent quantitative RT-PCR
Total RNA of were extracted from tumor tissues of the blank
group, no-load group, and the experimental group, and then
reversely transscripted into cDNA, respectively. Drawing the
same amount of cDNA template, real-time fluorescence
quantitative RT-PCR was performed for Ang2 to obtain RNAi
inhibition of Ang2 gene expression efficiency (Table 3).
Compared with no-load group, Ang2 mRNA expression
level of the experimental group was decreased by 70.7 %
(Fig. 9a), and the difference was statistically significant
(P \ 0.05); while Ang2 gene mRNA expression level, com-
pared with no-load group, blank group decreased by 8.17 %,
no statistical significance (P [ 0.05). Real time quantitative
RT-PCR products were separated by gel electrophoresis and
then pictured the result with a digital camera (Fig. 9b).
Discussion
Our study was focused on the expression of Ang2 gene and
how it affected the growth of malignant melanoma via tumor
angiogenesis and vessel growth. Ang2 is a member of an-
giopoietin family, secreted from the activated vascular
endothelial and playing a role in promoting differentiation
and activation of endothelial by autocrine pathway [14, 15],
which achieves these biological effect depending on exoge-
nous endothelial growth factor [16]. Its main function is
competitively binding with Ang receptor Tie2, inhibiting the
function of Ang1, including maintaining vascular blood
perfusion, vascular series, maturity and structural stability.
Ang2 can also enhance the sensitivity of endothelial to vas-
cular endothelial growth factor, so that it promote vascular
budding, growth and the formation of unstable vascular.
Matsunaga et al. [17], Saito et al. [18] and other studies have
reported Ang2 promoting vessel growth must rely on the
presence of vascular endothelial growth factor. When lack of
vascular endothelial growth factor, Ang2 inhibits role of
Ang1, leading to vessels diminishing. Ang2 expression level
in tumor tissue and circulating serum were significantly
higher than that in normal tissue surrounding tumor or normal
individuals. Helfrich et al. [19] found that Ang2 expression
level was relative with the development process of metastatic
malignant melanoma, and showed an important impact on the
ability of tumor invasion and metastasis. While the majority
of experiments show that the growth and metastasis of solid
tumors depend on tumor angiogenesis [20], suppression of
gene expression of Ang2, will affect tumor angiogenesis,
vessel growth, moreover, regulate tumor growth.









80 106 112 94.6
40 93 106 87.7
20 83 108 76.9
10 83 118 70.3
Table 2 The efficiency of RNAi inhibition of Ang2 mRNA expres-
sion level in the experimental group





A (Ct) 18.802 ± 0.544 0
B (Ct) 19.008 ± 1.109a 0.206
C (Ct) 20.460 ± 0.553b 1.658 68.31
D (Ct) 19.302 ± 0.454c 0.5 29.29
Group B and A: a P [ 0.05, Group C and A b P \ 0.05, Group D and
A c P [ 0.05
Fig. 7 The efficiency of Ang2 expression suppressed by RNAi.
A Control group, the relative expression levels of Ang2 was 100 %,
B EGFP-Ang2-I lent virus infection, the relative expression levels
Ang2 was 31.69 %, C EGFP-Ang2-II lent viral infection, the relative
amount expression of Ang2 was 70.71 %
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Angiogenesis means formation of new vessels via bud-
ding pathway based on primary vessels. There are two
main stages in proliferation and growth of solid tumors,
non-vascular stage and vascular stage. It has not been
reported that tumor own metastatic ability in non-vascular
stage. Neo vessels in the tumor bring rich blood supply and
nutrition from non-vascular stage to vascular stage.
Because of poor stability of the neo vascular structures and
the weak vascular wall, tumor cell s invade surrounding
normal organization crossing vascular wall, or enter the
blood circulation of long-distance systemic metastases. The
mechanism of angiogenesis is the disturbance of the tumor
growth microenvironment, the imbalance of pro-angio-
genic and anti- angiogenic factors [22], over-expression of
pro-angiogenic factors, and tumor angiogenesis. More
severe, Maniotis et al. [23] found that subcutaneous mel-
anoma had the vascular generation capacity independent on
the budding of endothelial cells to form vascular, and also
conduct blood and tissue fluid by duct which mimic vessel,
deformed by its own cells and extracellular matrix,
remodeling the tumor microenvironment.
According to the known sequence of mRNA of Ang2 as a
target, we successfully constructed recombinant plasmid of
pSilencer 1.0-U6-Ang2-siRNA. HUVECs were transfected
Fig. 8 Differences in
transplanted tumor of nude
mice. a Subcutaneous tumor of
nude mice at the end of
experiment, group 1, 2, 3,
represent the blank group, the
no-load group, the experimental
group, and the nude mice
subcutaneous tumor. b, c and d,
for the measurements of
subcutaneous tumor of blank
group, no-load group, the
experimental group,
respectively. e Diagram of
tumor volume, f tumor growth
curve
Table 3 The efficiency of RNAi inhibition of Ang2 mRNA expres-
sion level in the experimental group






No-load group (Ct) 8.865 ± 0.226 0
Blank group (Ct) 8.988 ± 0.101b 0.123 8.17
Experimental group (Ct) 10.636 ± 0.385a 1.771 70.70
Comparison of the experimental group and the no-load group:
b P \ 0.05, Comparison of the blank group and the no-load group:
a P [ 0.05
Fig. 9 a The efficiency of
RNAi inhibition of Ang2
mRNA expression level in the
experimental group.
b Expression level of Ang2
mRNA. M DNA Mark, lane 1,
3, 5 was the blank group, no-
load group, experimental group,
and lane 2, 4, 6 was standard
internal reference
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by liposome-mediated transfection, testing expression level
of Ang2 protein and mRNA, which was dominantly inhib-
ited. Transfected HUVECs were cultured in three-dimen-
sional culture model in vitro, and the number and length of
vessel-like structures were significantly reduced, which
denoted that angiogenesis was inhibited dominantly [5, 11].
All of the study illustrated that Ang2 could be a research
object to study the anti-angiogenesis of tumor.
On the basis of previous study, we successfully con-
structed lent virus expression vector of Ang2-siRNA by
application of transgenic technology and RNAi technology,
which inhibited Ang2 gene expression in malignant mela-
noma cells steadily. The primary virus liquid was used in
the experiment, and the titer of the virus is relatively low,
so we should select the appropriate multiplicity of infection
for later experiment. When the efficiency of virus infection
of malignant melanoma cells is 94.6 %, the multiplicity of
infection is 80, so multiplicity of infection of 80 was used
for infection test. The Ang2 gene expression levels of
malignant melanoma cell attenuated dominantly, causing
inhibition of angiogenesis, which is an important progress
of tumor genesis, so the inhibition of tumor growth, which
provided a new method of therapy in clinic.
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